Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma (GIPI)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2014 by Northern California Melanoma Center.
Recruitment status was  Active, not recruiting
University of California, San Francisco
Information provided by (Responsible Party):
Lynn E. Spitler, MD, Northern California Melanoma Center Identifier:
First received: May 27, 2011
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)